Abstract:Objective To evaluate the role of spinal neuronal microRNA-132 (miR-132) in a mouse model of bone cancer pain (BCP).Methods Male C3H/HeJ mice,aged 4-6 weeks,weighing 20-25 g,were used in the study.The experiment was performed in 2 parts.In experiment Ⅰ,fifty-two male C3H/HeJ mice were randomly divided into 2 groups (n =26 each) using a random number table:sham operation group (S group) and BCP group.In experiment Ⅱ,thirty-two male C3H/HeJ mice were randomly divided into 4 groups (n =8 each) using a random number table:sham operation + intrathecal DNAse/RNAse-free water group (S + Veh group),BCP + intrathecal DNAse/RNAse-free water group (BCP + Veh group),BCP + intrathecal negative control locked nucleic acid (LNA) group (BCP + C group),and BCP + intrathecal miR-132 antisense LNA group (BCP + AS group).BCP was induced by injecting 2 x 105 NCTC 2472 cells into the distal medullary cavity of the right tibia.In BCP+ C and BCP + AS groups,negative control LNA and miR-132 antisense LNA 12 pmol/5 μl were intrathecally injected,respectively,once a day for 7 consecutive days starting from day 14 after inoculation.In S + Veh and BCP + Veh groups,DNAse/RNAse-free water 5 μl was intrathecally injected once a day for 7 consecutive days starting frowm day 14 after inoculation.In S and BCP groups,the paw withdrawal threshold to mechanical stimuli (MWT) and the number of spontaneous flinches (NSF) were measured,and the expression of miR-132 in spinal cord was detected before inoculation and on 4,7,10,14 and 21 days after inoculation.In S + Veh,BCP + Veh,BCP + C and BCP + AS groups,the parameters mentioned above were measured at 14 days before inoculation and 15,16,17,18,19,20 and 21 days after inoculation.Results Compared with S group,MWT was significantly decreased,NSF was increased and the expression of miR-132 was up-regulated on 7-21 days after inoculation in BCP group.Compared with S + Veh group,MWT was significantly decreased,and NSF was increased at each time point in the other three groups.Compared with BCP + Veh group,MWT was significantly increased,and NSF was decreased on 16-21 days after inoculation in BCP + AS group.Conclusion Spinal neuronal miR-132 is involved in the development and maintenance of BCP in mice.

Mas-Related Gene (mrg) C Activation Attenuates Bone Cancer Pain Via Modulating Gi and NR2B

Activation of Spinal Mrgc-Gi-Nr2b-Nnos Signaling Pathway by Mas Oncogene-Related Gene C Receptor Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

Role of Spinal Neuronal Mas-related Gene Receptor C in Maintenance of Bone Cancer Pain in Mice

Mas-Related G-Protein-Coupled Receptor C Agonist Bovine Adrenal Medulla 8-22 Attenuates Bone Cancer Pain in Mice

Activation of Mas Oncogene-Related G Protein–Coupled Receptors Inhibits Neurochemical Alterations in the Spinal Dorsal Horn and Dorsal Root Ganglia Associated with Inflammatory Pain in Rats

MrgC Agonism at Central Terminals of Primary Sensory Neurons Inhibits Neuropathic Pain

<scp>USP48</scp> alleviates bone cancer pain and regulates <scp>MrgC</scp> stabilization in spinal cord neurons of male mice

Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

Activation of the BMP2-SMAD1-CGRP Pathway in Dorsal Root Ganglia Contributes to Bone Cancer Pain in a Rat Model

Relationship Between Spinal Neuronal Microrna 212 and Phosphorylation of CREB in a Mouse Model of Bone Cancer Pain

MiR-135-5p Alleviates Bone Cancer Pain by Regulating Astrocyte-Mediated Neuroinflammation in Spinal Cord through JAK2/STAT3 Signaling Pathway

Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model

Dorsal root ganglia NR2B-mediated Epac1-Piezo2 signaling pathway contributes to mechanical allodynia of bone cancer pain

Expression changes of metabotropic glutamate receptor 3 and 5 in spinal cord in a mouse model of bone cancer pain

Expression of NR2B in the Spinal Dorsal Horn and Dorsal Root Ganglia in Mice with Bone Cancer Pain

miR-155-5p in the spinal cord regulates hypersensitivity in a rat model of bone cancer pain

SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting Mglur1/5

Pain Behavior and the Expression of Phosphorylated Camp Response Element Binding Protein and Brain-Derived Neurotrophic Factor in Dorsal Horn of Spinal Cord in a Mouse Model of Bone Cancer Pain

Nerve Growth Factor/Tyrosine Kinase A Receptor Pathway Enhances Analgesia in an Experimental Mouse Model of Bone Cancer Pain by Increasing Membrane Levels of Δ-Opioid Receptors.

Upregulation of bone morphogenetic protein 2 ( Bmp2) in dorsal root ganglion in a rat model of bone cancer pain.

Role of Spinal Neuronal Microrna-132 in a Mouse Model of Bone Cancer Pain